Stock Quality:
ALIM RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2024 | 90.2M | 99.7M | 0 | 0 |
| 2023 | 55.8M | 58.7M | 68.5M | 80.8M |
| 2022 | 59.7M | 52.6M | 54.1M | 54.1M |
| 2021 | 47.5M | 59.2M | 58.8M | 59.0M |
| 2020 | 55.6M | 54.8M | 54.4M | 50.8M |
| 2019 | 49.9M | 50.0M | 51.7M | 53.9M |
| 2018 | 38.9M | 39.3M | 40.6M | 46.6M |
| 2017 | 35.1M | 36.0M | 37.4M | 35.9M |
| 2016 | 24.3M | 28.1M | 29.5M | 34.3M |
| 2015 | 10.3M | 13.9M | 18.4M | 22.4M |
| 2014 | 3.5M | 5.1M | 6.8M | 8.4M |
| 2013 | 0 | 0 | 0 | 1.9M |
| CEO | Mr. Richard S. Eiswirth Jr. |
|---|---|
| WEBSITE | https://alimerasciences.com |
| SECTOR | Healthcare |
| INDUSTRY | Drug Manufacturers Specialty & Generic |
| EMPLOYEES | 150 |